Hypertriglyceridemia: Causes and relation to coronary heart disease

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

This review indicates that hypertriglyceridemia in humans is a complex entity in that it can be the result of a host of causes, including primary, secondary, and dietary. Often multiple defects are present in a single person that accentuate the elevation of plasma triglycerides. Hypertriglyceridemia is further complicated because a variety of different forms of VLDL and chylomicrons may be present. These different forms probably vary in their atherogenic potential, although these differences have not been well defined. Finally, the presence of hypertriglyceridemia induces alterations in the metabolism of other lipoproteins - IDL, LDL, and HDL - that may modify the atherogenic potential of these lipoproteins. If hypertriglyceridemia were independently to affect the clotting system, this, too, would add to its connection with CHD. Thus, although the link between elevated levels of LDL cholesterol and CHD is understood in general terms, that between hypertriglyceridemia and CHD remains elusive.

Original languageEnglish (US)
Pages (from-to)149-164
Number of pages16
JournalSeminars in Thrombosis and Hemostasis
Volume14
Issue number2
StatePublished - 1988

Fingerprint

Hypertriglyceridemia
Coronary Disease
IDL Lipoproteins
Chylomicrons
HDL Lipoproteins
LDL Lipoproteins
LDL Cholesterol
Lipoproteins
Triglycerides

ASJC Scopus subject areas

  • Hematology

Cite this

Hypertriglyceridemia : Causes and relation to coronary heart disease. / Grundy, Scott M; Vega, Gloria L.

In: Seminars in Thrombosis and Hemostasis, Vol. 14, No. 2, 1988, p. 149-164.

Research output: Contribution to journalArticle

@article{2cdaf4ba4895419882fd4bd702f60296,
title = "Hypertriglyceridemia: Causes and relation to coronary heart disease",
abstract = "This review indicates that hypertriglyceridemia in humans is a complex entity in that it can be the result of a host of causes, including primary, secondary, and dietary. Often multiple defects are present in a single person that accentuate the elevation of plasma triglycerides. Hypertriglyceridemia is further complicated because a variety of different forms of VLDL and chylomicrons may be present. These different forms probably vary in their atherogenic potential, although these differences have not been well defined. Finally, the presence of hypertriglyceridemia induces alterations in the metabolism of other lipoproteins - IDL, LDL, and HDL - that may modify the atherogenic potential of these lipoproteins. If hypertriglyceridemia were independently to affect the clotting system, this, too, would add to its connection with CHD. Thus, although the link between elevated levels of LDL cholesterol and CHD is understood in general terms, that between hypertriglyceridemia and CHD remains elusive.",
author = "Grundy, {Scott M} and Vega, {Gloria L}",
year = "1988",
language = "English (US)",
volume = "14",
pages = "149--164",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Hypertriglyceridemia

T2 - Causes and relation to coronary heart disease

AU - Grundy, Scott M

AU - Vega, Gloria L

PY - 1988

Y1 - 1988

N2 - This review indicates that hypertriglyceridemia in humans is a complex entity in that it can be the result of a host of causes, including primary, secondary, and dietary. Often multiple defects are present in a single person that accentuate the elevation of plasma triglycerides. Hypertriglyceridemia is further complicated because a variety of different forms of VLDL and chylomicrons may be present. These different forms probably vary in their atherogenic potential, although these differences have not been well defined. Finally, the presence of hypertriglyceridemia induces alterations in the metabolism of other lipoproteins - IDL, LDL, and HDL - that may modify the atherogenic potential of these lipoproteins. If hypertriglyceridemia were independently to affect the clotting system, this, too, would add to its connection with CHD. Thus, although the link between elevated levels of LDL cholesterol and CHD is understood in general terms, that between hypertriglyceridemia and CHD remains elusive.

AB - This review indicates that hypertriglyceridemia in humans is a complex entity in that it can be the result of a host of causes, including primary, secondary, and dietary. Often multiple defects are present in a single person that accentuate the elevation of plasma triglycerides. Hypertriglyceridemia is further complicated because a variety of different forms of VLDL and chylomicrons may be present. These different forms probably vary in their atherogenic potential, although these differences have not been well defined. Finally, the presence of hypertriglyceridemia induces alterations in the metabolism of other lipoproteins - IDL, LDL, and HDL - that may modify the atherogenic potential of these lipoproteins. If hypertriglyceridemia were independently to affect the clotting system, this, too, would add to its connection with CHD. Thus, although the link between elevated levels of LDL cholesterol and CHD is understood in general terms, that between hypertriglyceridemia and CHD remains elusive.

UR - http://www.scopus.com/inward/record.url?scp=0023811206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023811206&partnerID=8YFLogxK

M3 - Article

C2 - 3061001

AN - SCOPUS:0023811206

VL - 14

SP - 149

EP - 164

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 2

ER -